Zeke Capital Advisors, LLC Lantern Pharma Inc. Transaction History

Zeke Capital Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$15.1 - $20.69 $1.28 Million - $1.75 Million	-84,750 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$10.7 - $21.25 $374,500 - $743,750	-35,000 Reduced 29.23%	84,750 $1.6 Million
Q2 2020 Jul 21, 2020	BUY	$11.54 - $14.95 $1.38 Million - $1.79 Million	119,750 New	119,750 $1.52 Million

1.28M

39.8K

6.1K

Ticker LTRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,830,900
Market Cap $55.9M
Description
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Zeke Capital Advisors, LLC with notifications on news.